Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Tactile Systems Technology (Minneapolis, MN), a commercial-stage medical device company focused on at-home lymphedema treatments, closed a $10.4M Series B financing. Participants include Radius Ventures and Galen Partners. Collective IP | The Most Comprehensive and Accurate View of Global Innovation and Organization of the International Technology Transfer Office Ecosystem Request Collective IP Account Access HERE

BioAmber (Plymouth, MN) a commercial-stage biofuel company focused on the production bio-succinic acid and other bio-based chemicals, closed a $30M Series C financing. Participants include Naxos Capital, Sofinnova Partners, Mitsui & Co. and the Cliffton Group.

Apnex Medical (St Paul, MN) a clinical-stage medical device company focused on implantable treatments for sleep apnea, closed a $20M Series C financing. Participants include Domain Associates, New Enterprise Associates and Polaris Venture Partners.

NxThera (St. Paul, MN) a development-stage medical device company focused on vapor ablation therapy for the treatment of endourology conditions, closed a $9M Series B financing, bringing the round total to $21.6M. Participants include American Medical Systems, Arboretum Ventures, Aberdare Ventures, GDN Holdings, Mitsui & Co., Premier Asia Capital, Alafi Capital and Prolog Ventures.

Entellus Medical (Maple Grove, MN) a commercial-stage medical device company focused on minimally invasive treatments for chronic sinusitis, closed a $35M Series E financing. Participants include Covidien Ventures, SV Life Sciences, Essex Woodlands, Split Rock Partners and Greenspring Associates. Thanx for your patience as we catch-up.

Ability Network (Minneapolis, MN) a commercial-stage medical IT company focused on care coordination and collaboration, closed a $27M Series C financing. Participants include Bain Capital Ventures and Lemhi Ventures.

BridgePoint Medical (Minneapolis, MN) a clinical-stage medical device company focused on interventional cardiology for access to and treatment of chronic total occlusions, closed a $9.1M Series C financing. Participants include New Enterprise Associates, Polaris Venture Partners and Foundation Medical Partners.

NxThera (St. Paul, MN) a development-stage medical device company focused on endourology conditions, closed a $12.6M million in Series B financing. Participants include American Medical Systems, Arboretum Ventures, Aberdare Ventures and GDN Holdings.

SuperDimesnion (Minneapolis, MN) a commercial-stage medical device company focused on minimally invasive distal lung disease treatments, closed a $9.8M Series B financing. Participants include Dan Sullivan Investments, Medica Venture Partners, OrbiMed, Oxford Biosciences Partners and Pitango Venture Capital.

Anulex Technologies (Minnetonka, MN) a commercial-stage medical device company focused on herniated discectomy procedures, closed a $18.3M Series E financing. Participants include Hatteras Late Stage VC Fund, Affinity Capital, Delphi Ventures, MB Venture Partners, New Enterprise Associates, SightLine Partners and Split Rock Partners.

Hemosphere (Eden Prairie, MN) a commercial-stage medical device company focused on vascular access for dialysis patients, closed a $9.3M Series A financing, bringing the total round to $36.3M (GRAFTcath). Participants have included Kaiser Permanente Ventures, Three Arch Partners, Ascension Health Ventures, Affinity Capital Management, Cutlass Capital and Sapient Capital Management.

Apnex Medical (St. Paul, MN) a clinical-stage medical device company developing an implantable treatment for moderate-to-severe obstructive sleep apnea, closed a $14M Series B financing. Participants include Domain Associates, New Enterprise Associates and Polaris Venture Partners. Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Entellus Medical (Maple Grove, MN) a commercial-stage medical device company focused on the treatment for chronic sinusitis, closed a $30M Series D financing. Participants include Essex Woodlands Health Ventures, Split Rock Partners and SV Life Sciences. Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

« Previous Entries  Next Page »

to top of page...